
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.740 | 0.740 | 0.000 |
Shares | 99.260 | 99.260 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 24.705 | 19.606 |
Price to Book | 3.805 | 3.867 |
Price to Sales | 3.404 | 2.210 |
Price to Cash Flow | 17.117 | 14.698 |
Dividend Yield | 0.918 | 1.499 |
5 Years Earnings Growth | 9.612 | 9.831 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 79.420 | 95.058 |
Consumer Cyclical | 6.600 | 7.019 |
Technology | 4.160 | 3.340 |
Basic Materials | 4.150 | 1.756 |
Industrials | 3.320 | 2.625 |
Consumer Defensive | 2.350 | 3.093 |
Number of long holdings: 40
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Boston Scientific | US1011371077 | 7.40 | 105.50 | -0.24% | |
Lonza Group | CH0013841017 | 5.49 | 567.00 | -0.46% | |
Eli Lilly | US5324571083 | 4.99 | 732.58 | +0.08% | |
Intuitive Surgical | US46120E6023 | 4.91 | 473.30 | -0.11% | |
Danaher | US2358511028 | 4.82 | 205.82 | +0.26% | |
Garmin | CH0114405324 | 4.13 | 241.82 | +0.32% | |
Planet Fitness Inc | US72703H1014 | 4.01 | 104.80 | -1.87% | |
AstraZeneca | GB0009895292 | 3.82 | 11,790.0 | -0.17% | |
STERIS | IE00BFY8C754 | 3.72 | 245.06 | +0.12% | |
HALEON | GB00BMX86B70 | 3.71 | 362.90 | +0.81% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
PIMegatrend Selection I EUR | 11.38B | -4.00 | 5.07 | 7.09 | ||
PIMegatrend Selection P dy EUR | 11.38B | -4.50 | 4.13 | 6.17 | ||
PIMegatrend Selection R EUR | 11.38B | -5.00 | 3.19 | 5.22 | ||
LU0474970273 | 11.38B | 2.96 | 4.39 | 3.20 | ||
LU0474969937 | 11.38B | 4.05 | 6.29 | 5.03 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review